The Lnc‐ENST00000602558/IGF1 axis as a predictor of response to treatment with tripterygium glycosides in rheumatoid arthritis patients

The Lnc‐ENST00000602558/IGF1 axis as a predictor of response to treatment with tripterygium glycosides in rheumatoid arthritis patients

Abstract Aims Growing clinical evidence suggests that not all patients with rheumatoid arthritis (RA) benefit to the same extent by treatment with tripterygium glycoside (TG), which highlights the need to identify RA‐related genes that can be used to predict drug responses. In addition, single genes...

Full description

Bibliographic Details
Main Authors: Yang Gao, Xiaoyue Wang, Yanfeng Gao, Jian Bai, Yanpeng Zhao, Renyi Wang, Hanzhou Wang, Guangzhao Zhu, Xixi Wang, Xiaochen Han, Yanqiong Zhang, Hailong Wang
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Immunity, Inflammation and Disease
Subjects:
IGF1
Lnc‐ENST00000602558
partial‐least‐squares
rheumatoid arthritis
tripterygium glycoside
Online Access:https://doi.org/10.1002/iid3.1098

Internet

https://doi.org/10.1002/iid3.1098

Similar Items